Immix Biopharma (IMMX) Treasury Shares (2022 - 2026)

Quarterly results put Treasury Shares at $99963.0 for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was $99963.0 (changed 0.0% YoY), and the annual figure for FY2025 was $99963.0, changed 0.0%.

Immix Biopharma has reported Treasury Shares over the past 5 years, most recently at $99963.0 for Q1 2026.

  • Treasury Shares reached $72363.0 in Q1 2026 per IMMX's latest filing, roughly flat from $72363.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $72363.0 in Q4 2022 and bottomed at -$72363.0 in Q4 2023.
  • Median Treasury Shares over the past 5 years was $37418.0 (2022), compared with a mean of $4677.2.
  • Peak annual rise in Treasury Shares hit 78.62% in 2023, while the deepest fall reached 0.0% in 2023.
  • Over 5 years, Treasury Shares stood at $99963.0 in 2022, then changed by 0.0% to $99963.0 in 2023, then changed by 0.0% to $99963.0 in 2024, then changed by 0.0% to $99963.0 in 2025, then changed by 0.0% to $99963.0 in 2026.
  • Business Quant data shows Treasury Shares for IMMX at $99963.0 in Q1 2026, $99963.0 in Q4 2025, and $99963.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 265,401.92
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 700,000.00
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 34.70 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -
10 Immix Biopharma 476.17 Mn 476.17 Mn - 99,963.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 72,363.00
Mar 31, 2026 99,963.00
Mar 31, 2026 72,363.00
Mar 31, 2026 99,963.00
Dec 31, 2025 99,963.00
Dec 31, 2025 72,363.00
Dec 31, 2025 72,363.00
Dec 31, 2025 99,963.00
Sep 30, 2025 72,363.00
Sep 30, 2025 99,963.00
Sep 30, 2025 99,963.00
Sep 30, 2025 72,363.00
Jun 30, 2025 -72,363.00
Jun 30, 2025 -72,363.00
Jun 30, 2025 99,963.00
Jun 30, 2025 99,963.00
Mar 31, 2025 99,963.00
Mar 31, 2025 99,963.00
Mar 31, 2025 -72,363.00
Mar 31, 2025 -72,363.00
Dec 31, 2024 -72,363.00
Dec 31, 2024 99,963.00
Dec 31, 2024 -72,363.00
Dec 31, 2024 99,963.00
Sep 30, 2024 99,963.00
Sep 30, 2024 -72,363.00
Sep 30, 2024 99,963.00
Sep 30, 2024 -72,363.00
Jun 30, 2024 99,963.00
Jun 30, 2024 99,963.00
Jun 30, 2024 -72,363.00
Jun 30, 2024 -72,363.00
Mar 31, 2024 -72,363.00
Mar 31, 2024 -72,363.00
Mar 31, 2024 99,963.00
Mar 31, 2024 99,963.00
Dec 31, 2023 99,963.00
Dec 31, 2023 99,963.00
Dec 31, 2023 -72,363.00
Dec 31, 2023 -72,363.00
Sep 30, 2023 72,363.00
Sep 30, 2023 72,363.00
Sep 30, 2023 99,963.00
Sep 30, 2023 99,963.00
Jun 30, 2023 99,963.00
Jun 30, 2023 99,963.00
Jun 30, 2023 72,363.00
Jun 30, 2023 72,363.00
Mar 31, 2023 99,963.00
Mar 31, 2023 99,963.00
Mar 31, 2023 72,363.00
Mar 31, 2023 72,363.00
Dec 31, 2022 99,963.00
Dec 31, 2022 99,963.00
Dec 31, 2022 72,363.00
Dec 31, 2022 72,363.00
Sep 30, 2022 37,418.00
Sep 30, 2022 37,418.00
Sep 30, 2022 55,963.00
Sep 30, 2022 55,963.00
Jun 30, 2022 37,418.00
Jun 30, 2022 37,418.00
Jun 30, 2022 55,963.00
Jun 30, 2022 55,963.00